Miller DD - Search Results

1

Current advances of tubulin inhibitors as dual acting small molecules for cancer therapy.

Arnst KE, Banerjee S, Chen H, Deng S, Hwang DJ, Li W, Miller DD. Arnst KE, et al. Among authors: miller dd. Med Res Rev. 2019 Jul;39(4):1398-1426. doi: 10.1002/med.21568. Epub 2019 Feb 11. Med Res Rev. 2019. PMID: 30746734 Free PMC article. Review.

2

Novel nonsteroidal ligands with high binding affinity and potent functional activity for the androgen receptor.

He Y, Yin D, Perera M, Kirkovsky L, Stourman N, Li W, Dalton JT, Miller DD. He Y, et al. Among authors: miller dd. Eur J Med Chem. 2002 Aug;37(8):619-34. doi: 10.1016/s0223-5234(02)01335-1. Eur J Med Chem. 2002. PMID: 12161060

3

Medetomidine analogs as selective agonists for the human alpha2-adrenoceptors.

Lalchandani SG, Zhang X, Hong SS, Liggett SB, Li W, Moore BM 2nd, Miller DD, Feller DR. Lalchandani SG, et al. Among authors: miller dd. Biochem Pharmacol. 2004 Jan 1;67(1):87-96. doi: 10.1016/j.bcp.2003.08.043. Biochem Pharmacol. 2004. PMID: 14667931

4

Synthesis and biological evaluation of novel cytotoxic phospholipids for prostate cancer.

Gududuru V, Hurh E, Durgam GG, Hong SS, Sardar VM, Xu H, Dalton JT, Miller DD. Gududuru V, et al. Among authors: miller dd. Bioorg Med Chem Lett. 2004 Oct 4;14(19):4919-23. doi: 10.1016/j.bmcl.2004.07.026. Bioorg Med Chem Lett. 2004. PMID: 15341952

5

SAR studies of 2-arylthiazolidine-4-carboxylic acid amides: a novel class of cytotoxic agents for prostate cancer.

Gududuru V, Hurh E, Sullivan J, Dalton JT, Miller DD. Gududuru V, et al. Among authors: miller dd. Bioorg Med Chem Lett. 2005 Sep 15;15(18):4010-3. doi: 10.1016/j.bmcl.2005.06.032. Bioorg Med Chem Lett. 2005. PMID: 16005217

6

Discovery of antiglioma activity of biaryl 1,2,3,4-tetrahydroisoquinoline derivatives and conformationally flexible analogues.

Mohler ML, Kang GS, Hong SS, Patil R, Kirichenko OV, Li W, Rakov IM, Geisert EE, Miller DD. Mohler ML, et al. Among authors: miller dd. J Med Chem. 2006 Sep 21;49(19):5845-8. doi: 10.1021/jm060020x. J Med Chem. 2006. PMID: 16970409

7

Structure-activity relationship studies of arylthiazolidine amides as selective cytotoxic agents for melanoma.

Li W, Wang Z, Gududuru V, Zbytek B, Slominski AT, Dalton JT, Miller DD. Li W, et al. Among authors: miller dd. Anticancer Res. 2007 Mar-Apr;27(2):883-8. Anticancer Res. 2007. PMID: 17465215 Free article.

8

Synthesis and antiproliferative activity of thiazolidine analogs for melanoma.

Li W, Lu Y, Wang Z, Dalton JT, Miller DD. Li W, et al. Among authors: miller dd. Bioorg Med Chem Lett. 2007 Aug 1;17(15):4113-7. doi: 10.1016/j.bmcl.2007.05.059. Epub 2007 May 23. Bioorg Med Chem Lett. 2007. PMID: 17561392

9

Cesium fluoride and tetra-n-butylammonium fluoride mediated 1,4-N-->O shift of disubstituted phenyl ring of a bicalutamide derivative.

Patil R, Li W, Ross CR, Kraka E, Cremer D, Mohler ML, Dalton JT, Miller DD. Patil R, et al. Among authors: miller dd. Tetrahedron Lett. 2006 Jun 5;47(23):3941-3944. doi: 10.1016/j.tetlet.2006.03.154. Tetrahedron Lett. 2006. PMID: 18079983 Free PMC article.

10

Synthesis and antiproliferative activity of imidazole and imidazoline analogs for melanoma.

Chen J, Wang Z, Lu Y, Dalton JT, Miller DD, Li W. Chen J, et al. Among authors: miller dd. Bioorg Med Chem Lett. 2008 Jun 1;18(11):3183-7. doi: 10.1016/j.bmcl.2008.04.073. Epub 2008 May 1. Bioorg Med Chem Lett. 2008. PMID: 18477505 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

841 results

Search Page

Filters